Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhus Toxicodendron 30 in Rheumatoid Arthritis
NCT01905735Phase 2Unknown
- Sponsor
- Healthcare Homoeo Charitable Society
- Start
- Aug 2013
- Primary completion
- Jan 2014
- Modality
- NPI (Non-Pharmacological Intervention), Homeopathic remedy, Plant Extract Therapy
- Countries
- 1
01
Overview
A Phase 2 trial of rhus toxicodendron in rheumatoid arthritis (RA), sponsored by Healthcare Homoeo Charitable Society. Status: unknown.
02
Drugs
rhus toxicodendron
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01905735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01905735.